Announcements Trials

Browse Landscape

Sponsor

Conditions

Acrocephalosyndactylia 5 Cholangiocarcinoma 3 Carcinoma, Transitional Cell 3 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Stomach Neoplasms 1 Recurrence 1 Oligodendroglioma 1 Neoplasms, Unknown Primary 1 Multiple Myeloma 1 Lung Neoplasms 1 Glioma 1 Glioblastoma 1 Eosinophilia 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Advanced Malignancies 1

Interventions

Gemcitabine 6 Irinotecan 4 130-nm albumin-bound paclitaxel 4 Cisplatin 3 Albumin-Bound Paclitaxel 3 napabucasin 2 Leucovorin 2 Imatinib Mesylate 2 Everolimus 2 Ascorbic Acid 2 spartalizumab 1 pralsetinib 1 pembrolizumab 1 dostarlimab 1 copanlisib 1 alectinib 1 Ramucirumab 1 Paclitaxel 1 NUC-1031 1 Levoleucovorin 1 KRN-330 1 HhAntag691 1 Fluorouracil 1 Cyclophosphamide 1 Capecitabine 1 Bevacizumab 1 5,10-methylenetetrahydrofolic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Digestive System Neoplasms × pemigatinib × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡